Document:

Exhibit
10.2

 

COMPANY
STOCKHOLDER SUPPORT AGREEMENT 1

 

This COMPANY STOCKHOLDER SUPPORT
AGREEMENT, dated as of January 12, 2022 (this “Agreement”), is entered into by and among the stockholders listed on
Exhibit A hereto (each, a “Stockholder”), Suneva Medical, Inc., a Delaware corporation (the “Company”),
and Viveon Health Acquisition Corp., a Delaware corporation (“Parent”). Capitalized terms used but not defined in this
Agreement shall have the meanings ascribed to them in the Merger Agreement (as defined below).

 

WHEREAS, Parent, VHAC Merger
Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent (“Merger Sub”), and the Company are parties
to that certain Merger Agreement, dated as of the date hereof, as amended, modified or supplemented from time to time (the “Merger
Agreement”), which provides, among other things, that, upon the terms and subject to the conditions thereof, Merger Sub will
be merged with and into the Company (the “Merger”), with the Company surviving the Merger as a direct wholly-owned
subsidiary of Parent;

 

WHEREAS,
as of the date hereof, each Stockholder owns the number of shares of the Company’s common stock, par value $0.001 (“Company
Common Stock”), and the Company’s Preferred Stock, par value $0.001 per share (“Company Preferred Stock”),
as set forth on Exhibit A (all such shares, or any successor or additional shares of the Company of which ownership of record
or the power to vote is hereafter acquired by the Stockholder prior to the termination of this Agreement being referred to herein as
the “Stockholder Shares”); and

 

WHEREAS,
in order to induce the Company and Parent to enter into the Merger Agreement, each Stockholder is executing and delivering this Agreement
to the Parent.

 

NOW,
THEREFORE, in consideration of the foregoing and of the mutual covenants and agreements contained herein, and intending to be legally
bound hereby, the parties hereby agree as follows:

 

1.
Voting Agreements. Each Stockholder, in its capacity as a stockholder of the Company, agrees that, at any meeting of the Company’s
stockholders related to the transactions contemplated by the Merger Agreement (whether annual or special and whether or not an adjourned
or postponed meeting, however called and including any adjournment or postponement thereof) and/or in connection with any written consent
of the Company’s stockholders related to the transactions contemplated by the Merger Agreement (all meetings or consents related
to the Merger Agreement, collectively referred to herein as the “Meeting”), such Stockholder shall:

 

		(a)	when
                                            the Meeting is held, appear at the Meeting or otherwise cause the Stockholder Shares to be
                                            counted as present thereat for the purpose of establishing a quorum;

 

		(b)	vote
                                            (or execute and return an action by written consent), or cause to be voted at the Meeting
                                            (or validly execute and return and cause such consent to be granted with respect to), all
                                            of the Stockholder Shares in favor of the Merger, the Merger Agreement and the transactions
                                            contemplated thereby;

 

 

     

     

    

 

		(c)	authorize
                                            and approve any amendment to the Company’s organizational documents that is deemed
                                            necessary or advisable by the Company for purposes of effecting the transactions contemplated
                                            by the Merger Agreement; and

 

		(d)	vote
                                            (or execute and return an action by written consent), or cause to be voted at the Meeting
                                            (or validly execute and return and cause such consent to be granted with respect to), all
                                            of the Stockholder Shares against any other action that, to the knowledge of Stockholder,
                                            would reasonably be expected to (x) impede, interfere with, delay, postpone or materially
                                            and adversely affect the Merger or any of the transactions contemplated by the Merger Agreement,
                                            or (y) result in a breach of any covenant, representation or warranty or other obligation
                                            or agreement of the Stockholder contained in this Agreement.

 

2.
Restrictions on Transfer. The Stockholder agrees that it shall not sell, assign or otherwise transfer any of the Stockholder Shares
unless the buyer, assignee or transferee thereof executes a joinder agreement to this Agreement in a form reasonably acceptable to Parent.
The Company shall not register any sale, assignment or transfer of the Stockholder Shares on the Company’s stock ledger (book entry
or otherwise) that is not in compliance with this Section 2.

 

3.
New Securities. During the period commencing on the date hereof and ending on the earlier to occur of (a) the Effective Time (as
defined in the Merger Agreement), and (b) such date and time as the Merger Agreement shall be terminated, in the event that, (i) any
shares of Company Capital Stock or other equity securities of Company are issued to the Stockholder after the date of this Agreement
pursuant to any stock dividend, stock split, recapitalization, reclassification, combination or exchange of Company securities owned
by the Stockholder, (ii) the Stockholder purchases or otherwise acquires beneficial ownership of any shares of Company Capital Stock
or other equity securities of Company after the date of this Agreement, or (iii) the Stockholder acquires the right to vote or share
in the voting of any Company Capital Stock or other equity securities of Company after the date of this Agreement (such Company Capital
Stock or other equity securities of Parent, collectively the “New Securities”), then such New Securities acquired
or purchased by the Stockholder shall be subject to the terms of this Agreement to the same extent as if they constituted the Stockholder
Shares as of the date hereof.

 

4.
No Challenge. Each Stockholder agrees not to commence, join in, facilitate, assist or encourage, and agrees to take all actions
necessary to opt out of any class in any class action with respect to, any claim, derivative or otherwise, against the Parent, Merger
Sub, the Company or any of their respective successors or directors (a) challenging the validity of, or seeking to enjoin the operation
of, any provision of this Agreement or the Merger Agreement or (b) alleging a breach of any fiduciary duty of any person in connection
with the evaluation, negotiation or entry into the Merger Agreement.

 

5.
Waiver. Each Stockholder hereby irrevocably and unconditionally waives any rights of appraisal, dissenter’s rights and any
similar rights relating to the Merger Agreement and the consummation by the parties of the transactions contemplated thereby, including
the Merger, that such Stockholder may have under applicable law (including Section 262 of the DGCL or otherwise), (ii) consents to, on
behalf of itself, and each other holder of Company Preferred Stock and irrevocably and unconditionally waives any and all rights such
Stockholder may have with respect to, the conversion of all outstanding shares of Company Preferred Stock into shares of Company Common
Stock, with such conversion to be in accordance with the terms of the Company’s organizational documents and effective as of immediately
prior to the Effective Time, and (iii) waives, on behalf of themselves and each other holder of Company Capital Stock (including Company
Preferred Stock), its right to certain payments upon liquidation of the Company pursuant to the Company’s organizational documents.

 

    2

     

    

 

6.
Consent to Disclosure. Each Stockholder hereby consents to the publication and disclosure in the Form S-4 and the Proxy Statement
(and, as and to the extent otherwise required by applicable securities Laws or the SEC or any other securities authorities, any other
documents or communications provided by the Parent or the Company to any Authority (as defined in the Merger Agreement) or to securityholders
of the Parent) of such Stockholder’s identity and beneficial ownership of Stockholder Shares and the nature of such Stockholder’s
commitments, arrangements and understandings under and relating to this Agreement and, if deemed appropriate by the Parent or the Company,
a copy of this Agreement. Each Stockholder will promptly provide any information reasonably requested by the Parent or the Company for
any regulatory application or filing made or approval sought in connection with the transactions contemplated by the Merger Agreement
(including filings with the SEC).

 

7.
Stockholder Representations: Each Stockholder represents and warrants to Parent and the Company, as of the date hereof, that:

 

		(a)	such
                                            Stockholder has full right and power, without violating any agreement to which it is bound
                                            (including, without limitation, any non-competition or non-solicitation agreement with any
                                            employer or former employer), to enter into this Agreement;

 

		(b)	(i)
                                            if such Stockholder is not an individual, such Stockholder is duly organized, validly existing
                                            and in good standing under the Laws of the jurisdiction in which it is organized, and the
                                            execution, delivery and performance of this Agreement and the consummation of the transactions
                                            contemplated hereby are within such Stockholder’s organizational powers and have been
                                            duly authorized by all necessary organizational actions on the part of the Stockholder and
                                            (ii) if such Stockholder is an individual, the signature on this Agreement is genuine, and
                                            such Stockholder has legal competence and capacity to execute the same;

 

		(c)	this
                                            Agreement has been duly executed and delivered by such Stockholder and, assuming due authorization,
                                            execution and delivery by the other parties to this Agreement, this Agreement constitutes
                                            a legally valid and binding obligation of such Stockholder, enforceable against such Stockholder
                                            in accordance with the terms hereof (except as enforceability may be limited by bankruptcy
                                            Laws, other similar Laws affecting creditors’ rights and general principles of equity
                                            affecting the availability of specific performance and other equitable remedies);

 

		(d)	the
                                            execution and delivery of this Agreement by such Stockholder does not, and the performance
                                            by such Stockholder of its obligations hereunder will not, (i) conflict with or result in
                                            a violation of the organizational documents of such Stockholder, or (ii) require any consent
                                            or approval from any third party that has not been given or other action that has not been
                                            taken by any third party, in each case, to the extent such consent, approval or other action
                                            would prevent, enjoin or materially delay the performance by such Stockholder of its obligations
                                            under this Agreement;

 

		(e)	there
                                            are no Actions (as defined in the Merger Agreement) pending against such Stockholder or,
                                            to the knowledge of such Stockholder, threatened against such Stockholder, before (or, in
                                            the case of threatened Actions, that would be before) any Authority, which in any manner
                                            challenges or seeks to prevent, enjoin or materially delay the performance by such Stockholder
                                            of such Stockholder’s obligations under this Agreement;

 

    3

     

    

 

		(f)	no
                                            broker, finder, investment banker or other Person is entitled to any brokerage fee, finders’
                                            fee or other commission in connection with this Agreement or any of the respective transactions
                                            contemplated hereby, based upon arrangements made by the Stockholder or, to the knowledge
                                            of such Stockholder, by the Company;

 

		(g)	such
                                            Stockholder has had the opportunity to read the Merger Agreement and this Agreement and has
                                            had the opportunity to consult with such Stockholder’s tax and legal advisors;

 

		(h)	such
                                            Stockholder has not entered into, and shall not enter into, any agreement that would prevent
                                            such Stockholder from performing any of such Stockholder’s obligations hereunder;

 

		(i)	such
                                            Stockholder has good title to the Stockholder Shares opposite such Stockholder’s name
                                            on Exhibit A, free and clear of any Liens other than Permitted Liens, and such Stockholder
                                            has the sole power to vote or cause to be voted such Stockholder Shares; and

 

		(j)	the
                                            Stockholder Shares identified in Section 2 of this Agreement are the only shares of
                                            the Company’s outstanding capital stock owned of record or beneficially owned by the
                                            Stockholder as of the date hereof, and none of such Stockholder Shares are subject to any
                                            proxy, voting trust or other agreement or arrangement with respect to the voting of such
                                            Stockholder Shares that is inconsistent with such Stockholder’s obligations pursuant
                                            to this Agreement.

 

8.
Damages; Remedies. Except as otherwise expressly provided herein, any and all remedies provided herein will be deemed cumulative
with and not exclusive of any other remedy conferred hereby, or by law or equity upon such party, and the exercise by a party of any
one remedy will not preclude the exercise of any other remedy. The Stockholder hereby agrees and acknowledges that (a) Parent and the
Company would be irreparably injured in the event of a breach by the Stockholder of its obligations under this Agreement, (b) monetary
damages may not be an adequate remedy for such breach and (c) the non-breaching party shall be entitled to an injunction or injunctions,
specific performance and other equitable relief to prevent breaches of this Agreement and to enforce specifically the terms and provisions
of this Agreement, in each case, without posting a bond or undertaking and without proof of damages and this being in addition to any
other remedy to which they are entitled at law or in equity. Each of the parties agrees that it will not oppose the granting of an injunction,
specific performance and other equitable relief when expressly available pursuant to the terms of this Agreement on the basis that the
other party has an adequate remedy at law or an award of specific performance is not an appropriate remedy for any reason at law or equity.

 

9.
Entire Agreement; Amendment. This Agreement and the other agreements referenced herein constitute the entire agreement and understanding
of the parties hereto in respect of the subject matter hereof and supersede all prior and contemporaneous understandings and agreements
related hereto (whether written or oral), to the extent they relate in any way to the subject matter hereof or the transactions contemplated
hereby. No provision of this Agreement may be explained or qualified by any agreement, negotiations, understanding, discussion, conduct
or course of conduct or by any trade usage. Except as otherwise expressly stated herein, there is no condition precedent to the effectiveness
of any provision hereof. This Agreement may not be changed, amended or modified as to any particular provision, except by a written instrument
executed by all parties hereto, and cannot be terminated orally or by course of conduct. No provision hereof can be waived, except by
a writing signed by the party against whom such waiver is to be enforced, and any such waiver shall apply only in the particular instance
in which such waiver shall have been given.

 

    4

     

    

 

10.
Assignment. No party hereto may, except as set forth herein, assign either this Agreement or any of its rights, interests, or
obligations hereunder, including by merger, consolidation, operation of law or otherwise, without the prior written consent of the other
parties. Any purported assignment or delegation in violation of this paragraph shall be void and ineffectual, and shall not operate to
transfer or assign any interest or title to the purported assignee. This Agreement shall be binding on the Stockholder, the Parent and
the Company and each of their respective successors, heirs, personal representatives and assigns and permitted transferees.

 

11.
Counterparts. This Agreement may be executed in any number of original, electronic or facsimile counterparts and each of such
counterparts shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the
same instrument. This Agreement shall become effective upon delivery to each party of an executed counterpart or the earlier delivery
to each party of original, photocopied, or electronically transmitted signature pages that together (but need not individually) bear
the signatures of all other parties.

 

12.
Severability. This Agreement shall be deemed severable, and a determination by a court or other legal authority that any provision
that is not of the essence of this Agreement is legally invalid shall not affect the validity or enforceability of this Agreement or
of any other term or provision hereof. Furthermore, the parties shall cooperate in good faith to substitute (or cause such court or other
legal authority to substitute) for any provision so held to be invalid a valid provision, as alike in substance to such invalid or unenforceable
provision as may be possible and be valid and enforceable.

 

13.
Governing Law; Jurisdiction; Jury Trial Waiver. Section 11.7, Section 11.15 and Section 11.16 of the Merger Agreement are incorporated
by reference herein to apply with full force to any disputes arising under this Agreement.

 

14.
Notice. Any notice, consent or request to be given in connection with any of the terms or provisions of this Agreement shall be
in writing and shall be sent or given in accordance with the terms of Section 11.1 of the Merger Agreement to the applicable party, with
respect to the Company and Parent, at the respective addresses set forth in Section 11.1 of the Merger Agreement, and, with respect to
Stockholder, at the address set forth on Exhibit A.

 

15.
Termination. This Agreement shall terminate on the earlier of the (i) Closing,(ii) termination of the Merger Agreement, or (iii)
failure of the Parent’s stockholders to approve an Extension Proposal (as defined in the Merger Agreement) at any special meeting
of the Parent’s stockholders required to be held in connection with such Extension Proposal. No such termination shall relieve
the Stockholder, Parent or the Company from any liability resulting from a breach of this Agreement occurring prior to such termination.

 

16.
Adjustment for Stock Split. If, and as often as, there are any changes in the Stockholder Shares by way of stock split, stock
dividend, combination or reclassification, or through merger, consolidation, reorganization, recapitalization or business combination,
or by any other means, equitable adjustment shall be made to the provisions of this Agreement as may be required so that the rights,
privileges, duties and obligations hereunder shall continue with respect to the Stockholder, Parent, the Company, the Stockholder Shares
as so changed.

 

17.
Further Actions. Each of the parties hereto agrees to execute and deliver hereafter any further document, agreement or instrument
of assignment, transfer or conveyance as may reasonably be considered within the scope of such party’s obligations hereunder, as
may be necessary or desirable to effectuate the purposes hereof.

 

[remainder
of page intentionally left blank]

 

    5

     

    

 

IN
WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

 

	 	SUNEVA MEDICAL, INC.

	 	 	 
	 	By:	                       
	 	 	Name:  
	 	 	Title:  

 

	 	VIVEON
HEALTH ACQUISITION CORP.

	 	 	 
	 	By:	                       
	 	 	Name:  
	 	 	Title:  

 

	 	[STOCKHOLDER]

	 	 	 
	 	By:	                       
	 	 	Name:  
	 	 	Title:  

 

	 	[STOCKHOLDER]

	 	 	 
	 	By:	                       
	 	 	Name:  
	 	 	Title:  

 

     

     

    

 

Exhibit
A

 

Stockholders

 

	Stockholder
	 	Number
    of Shares
	 	Address
    for Notices

	 	 	 	 	 
	EW
    Healthcare Partners, L.P.	 	[TBD
    based on waterfall]	 	c/o
    Essex Woodlands

    21
    Waterway Avenue, Suite 225

    The
    Woodlands, TX 77380

    Attn:
    Ron Eastman

    F:
    281 364 9755

	 	 	 	 	 
	EW
    Healthcare Partners-A, L.P.	 	[TBD
    based on waterfall]	 	c/o
    Essex Woodlands

    21
    Waterway Avenue, Suite 225

    The
    Woodlands, TX 77380

    Attn:
    Ron Eastman

    F:
    281 364 9755

	 	 	 	 	 
	HCR
    Molag Fund, L.P.	 	[TBD
    based on waterfall]	 	c/o
    Healthcare Royalty Partners, L.P.

    300
    Atlantic Street, Suite 600

    Stamford,
    CT 06901

	 	 	 	 	 
	MOLAG
    HealthCare Royalty, LLC	 	[TBD
    based on waterfall]	 	c/o
    Healthcare Royalty Partners, L.P.

    300
    Atlantic Street, Suite 600

    Stamford,
    CT 06901

	 	 	 	 	 
	Polaris
    Venture Partners Founders’ Fund VI, L.P.	 	[TBD
    based on waterfall]	 	One
    Marina Park Drive, 10th Floor

    Boston,
    MA 02210

    Attn:
    Lauren Crockett

	 	 	 	 	 
	Polaris
    Venture Partners VI, L.P.	 	[TBD
    based on waterfall]	 	One
    Marina Park Drive, 10th Floor

    Boston,
    MA 02210

    Attn:
    Lauren Crockett

	 	 	 	 	 
	Avenue
    Venture Opportunities Fund, LP	 	[TBD
    based on waterfall – Note Avenue’s warrant will be exercised for Series AA by virtue of the de-SPAC (per the warrants
    terms) and then converted to Common of Parent in the merger]	 	11
    West 42nd Street, 9th Floor

    New
    York, New York 10036

    Attn:
    Todd Greenbarg, Senior Managing Director

    Email:
    tgreenbarg@avenuecapital.com

    Phone
    # 212-878-3523Exhibit
10.3

 

LOCK-UP
AGREEMENT

 

THIS LOCK-UP AGREEMENT (this
“Agreement”) is dated as of January 12, 2022 by and between the undersigned stockholder (the “Holder”)
and Viveon Health Acquisition Corp., a Delaware corporation (the “Parent”).

 

A. Parent, VHAC Merger Sub, Inc., a Delaware corporation and wholly-owned
subsidiary of Parent, and Suneva Medical, Inc., a Delaware corporation (the “Company”), entered into a Merger Agreement
dated as of January 12, 2022 (the “Merger Agreement”). Capitalized terms used, but not otherwise defined herein, shall
have the meanings ascribed to such terms in the Merger Agreement.

 

B.
Pursuant to the Merger Agreement, Parent will become the 100% stockholder of the Company.

 

C.
The Holder is the record and/or beneficial owner of certain shares of Company Capital Stock (as defined in the Merger Agreement), which
pursuant to the Merger Agreement will be exchanged for shares of Parent Common Stock (as defined in the Merger Agreement).

 

D.
As a condition of, and as a material inducement for Parent to enter into and consummate the transactions contemplated by the Merger Agreement,
the Holder has agreed to execute and deliver this Agreement.

 

NOW,
THEREFORE, for and in consideration of the mutual covenants and agreements set forth herein, and other good and valuable consideration,
the receipt and sufficiency of which is hereby acknowledged, the parties, intending to be legally bound, agree as follows:

 

AGREEMENT

 

1.
Lock-Up.

 

(a)
Subject to Section 1(b) below, during the Lock-up Period, the Holder agrees that it, he or she will not offer, sell, contract to sell,
pledge or otherwise dispose of, directly or indirectly, any of the Lock-up Shares (as defined below), enter into a transaction that would
have the same effect, or enter into any swap, hedge or other arrangement that transfers, in whole or in part, any of the economic consequences
of ownership of the Lock-up Shares or otherwise, publicly disclose the intention to make any offer, sale, pledge or disposition, or to
enter into any transaction, swap, hedge or other arrangement, or engage in any Short Sales (as defined below) with respect to the Lock-up
Shares; provided, that if the closing price of the Parent Common Stock equals or exceeds $12.50 per share (as adjusted for stock
splits, stock dividends, reorganizations and recapitalizations) for any 20 trading days within any 30-trading day period following the
consummation of the Business Combination, fifty percent (50%) of the Lock-up Shares shall be released from the lock-up.

 

(b)
In furtherance of the foregoing, during the Lock-up Period, the Parent will (i) place a stop order on all the Lock-up Shares, including
those which may be covered by a registration statement, and (ii) notify the Parent’s transfer agent in writing of the stop order
and the restrictions on the Lock-up Shares under this Agreement and direct the Parent’s transfer agent not to process any attempts
by the Holder to resell or transfer any Lock-up Shares, except in compliance with this Agreement.

  

(c)
For purposes hereof, “Short Sales” include, without limitation, all “short sales” as defined in Rule 200
promulgated under Regulation SHO under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and all
types of direct and indirect stock pledges, forward sale contracts, options, puts, calls, swaps and similar arrangements (including on
a total return basis), and sales and other transactions through non-US broker dealers or foreign regulated brokers.

 

(d)
The term “Lock-up Period” means the date that is six (6) months after the Closing Date (as defined in the Merger Agreement),
subject to earlier termination of the Lock-up Period as to fifty percent (50%) of the Lock-up Shares, as provided in Section 1(a).

 

     

     

    

 

2. Beneficial
Ownership. The Holder hereby represents and warrants that it does not beneficially own, directly or through its nominees (as
determined in accordance with Section 13(d) of the Exchange Act, and the rules and regulations promulgated thereunder), any shares
of Parent Common Stock, or any economic interest in or derivative of such shares, other than those shares of Parent Common Stock
issued pursuant to the Merger Agreement. For purposes of this Agreement, the Merger Consideration Shares beneficially owned by the
Holder, together with any other shares of Parent Common Stock, and including any securities convertible into, or exchangeable for,
or representing the rights to receive Parent Common Stock, if any, acquired during the Lock-up Period are collectively referred to
as the “Lock-up Shares,” provided, however, that such Lock-up Shares shall not include shares of
Parent Common Stock acquired by such Holder in open market transactions during the Lock-up Period.

 

Notwithstanding
the foregoing, and subject to the conditions below, the undersigned may transfer Lock-Up Shares in connection with (a) transfers or distributions
to the Holder’s direct or indirect affiliates (within the meaning of Rule 405 under the Securities Act of 1933, as amended) or
to the estates of any of the foregoing; (b) transfers by bona fide gift or gifts to a member of the Holder’s immediate family or
to a trust, the beneficiary of which is the Holder or a member of the Holder’s immediate family for estate planning purposes; (c)
by virtue of a will, testamentary document or the laws of descent and distribution upon death of the Holder; (d) pursuant to a qualified
domestic relations order or as required by a divorce settlement, (e) transfers to the Parent’s officers, directors or their affiliates,
(f) pledges of Lock-up Shares as security or collateral in connection with a borrowing or the incurrence of any indebtedness by the Holder,
provided, however, that such borrowing or incurrence of indebtedness is secured by either a portfolio of assets or equity
interests issued by multiple issuers, (g) transfers pursuant to a bona fide third-party tender offer, merger, stock sale, recapitalization,
consolidation or other transaction involving a change of control of Parent; provided, however, that in the event that such
tender offer, merger, recapitalization, consolidation or other such transaction is not completed, the Lock-Up Shares subject to this
Agreement shall remain subject to this Agreement, (h) the establishment of a trading plan pursuant to Rule 10b5-1 promulgated under the
Exchange Act; provided, however, that such plan does not provide for the transfer of Lock-up Shares during the Lock-Up
Period, (i) transfers to satisfy tax withholding obligations in connection with the exercise of options to purchase shares of Parent
Common Stock or the vesting of stock-based awards; and (j) transfers in payment on a “net exercise” or “cashless”
basis of the exercise or purchase price with respect to the exercise of options to purchase shares of Parent Common Stock; provided,
however, that, in the case of any transfer pursuant to the foregoing (a) through (e) clauses, it shall be a condition to any such
transfer that (i) the transferee/donee agrees to be bound by the terms of this Agreement (including, without limitation, the restrictions
set forth in the preceding sentence) to the same extent as if the transferee/donee were a party hereto; and (ii) each party (donor, donee,
transferor or transferee) shall not be required by law (including without limitation the disclosure requirements of the Securities Act
of 1933, as amended (the “Securities Act”), and the Exchange Act) to make, and shall agree to not voluntarily make,
any filing or public announcement of the transfer or disposition prior to the expiration of the Lock-Up Period.

 

3.
Representations and Warranties. Each of the parties hereto, by their respective execution and delivery of this Agreement, hereby
represents and warrants to the other that (a) such party has the full right, capacity and authority to enter into, deliver and perform
its respective obligations under this Agreement, (b) this Agreement has been duly executed and delivered by such party and is a binding
and enforceable obligation of such party and, enforceable against such party in accordance with the terms of this Agreement, and (c)
the execution, delivery and performance of such party’s obligations under this Agreement will not conflict with or breach the terms
of any other agreement, contract, commitment or understanding to which such party is a party or to which the assets or securities of
such party are bound. The Holder has independently evaluated the merits of his/her/its decision to enter into and deliver this Agreement,
and such Holder confirms that he/she/it has not relied on the advice of Company, Company’s legal counsel, or any other person.

 

4.
No Additional Fees/Payment. Other than the consideration specifically referenced herein, the parties hereto agree that no fee,
payment or additional consideration in any form has been or will be paid to the Holder in connection with this Agreement.

 

    2

     

    

 

5.
Notices. Any notices required or permitted to be sent hereunder shall be sent in writing, addressed as specified below, and shall
be deemed given: (a) if by hand, electronic mail, or nationally recognized overnight courier service, by 5:00 PM Pacific Time on a Business
Day, addressee’s day and time, on the date of delivery, and if delivered after 5:00 PM Eastern Time, on the first Business Day
after such delivery; (b) if by email, on the date that transmission with affirmative confirmation of receipt; or (c) three (3) Business
Days after mailing by prepaid certified or registered mail, return receipt requested. Notices shall be addressed to the respective parties
as follows (excluding telephone numbers, which are for convenience only), or to such other address as a party shall specify to the others
in accordance with these notice provisions:

 

(a)
If to Company, to:

Suneva
Medical, Inc.

5870 Pacific Center Blvd.

San Diego, CA 92121

Attn; Patricia Altavilla, President and Chief Executive Officer

E-mail: paltavilla@sunevamedical.com

  

with
a copy to (which copy shall not constitute notice):

 

Cooley
LLP

4401
Eastgate Mall

San
Diego, CA 92121-1909

Attn:
Barbara Borden, Esq.

E-mail:
bordenbl@cooley.com

 

if
to Parent or Merger Sub (prior to the Closing):

 

Viveon
Health Acquisition Corporation

c/o
Gibson, Deal & Fletcher, PC

Spalding
Exchange

3953
Holcomb Bridge Road

Suite
200

Norcross,
GA 30092

Attn:
Jagi Gill, Chief Executive Officer

E-mail:
jagi@viveonhealth.com

 

with
a required copy to (which copy shall not constitute notice):

 

Loeb
& Loeb LLP

345 Park Avenue, 19th Floor

New York, NY 10154

Attention: Tahra Wright

E-mail: twright@loeb.com

 

(b)
If to the Holder, to the address set forth on the Holder’s signature page hereto, with a copy, which shall not constitute notice,
to:

 

_________________________________

_________________________________

_________________________________

Email:

 

or
to such other address(es) as any party may have furnished to the others in writing in accordance herewith.

 

6.
Enumeration and Headings. The enumeration and headings contained in this Agreement are for convenience of reference only and shall
not control or affect the meaning or construction of any of the provisions of this Agreement.

 

7.
Counterparts. This Agreement may be executed in any number of original, electronic or facsimile counterparts and each of such
counterparts shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the
same instrument. This Agreement shall become effective upon delivery to each party of an executed counterpart or the earlier delivery
to each party of original, photocopied, or electronically transmitted signature pages that together (but need not individually) bear
the signatures of all other parties.

 

    3

     

    

 

8.
Successors and Assigns. This Agreement and the terms, covenants, provisions and conditions hereof shall be binding upon, and shall
inure to the benefit of, the respective heirs, successors and assigns of the parties hereto. The Holder hereby acknowledges and agrees
that this Agreement is entered into for the benefit of and is enforceable by Company and its successors and assigns. No party hereto
may, except as set forth herein, assign either this Agreement or any of its rights, interests, or obligations hereunder, including by
merger, consolidation, operation of law or otherwise, without the prior written consent of the other parties. Any purported assignment
or delegation in violation of this paragraph shall be void and ineffectual, and shall not operate to transfer or assign any interest
or title to the purported assignee.

 

9.
Severability. This Agreement shall be deemed severable, and a determination by a court or other legal authority that any provision
that is not of the essence of this Agreement is legally invalid shall not affect the validity or enforceability of this Agreement or
of any other term or provision hereof. Furthermore, the parties shall cooperate in good faith to substitute (or cause such court or other
legal authority to substitute) for any provision so held to be invalid a valid provision, as alike in substance to such invalid or unenforceable
provision as may be possible and be valid and enforceable.

 

10.
Entire Agreement; Amendment. This Agreement and the other agreements referenced herein constitute the entire agreement and understanding
of the parties hereto in respect of the subject matter hereof and supersede all prior and contemporaneous understandings and agreements
related hereto (whether written or oral), to the extent they relate in any way to the subject matter hereof or the transactions contemplated
hereby. No provision of this Agreement may be explained or qualified by any agreement, negotiations, understanding, discussion, conduct
or course of conduct or by any trade usage. Except as otherwise expressly stated herein, there is no condition precedent to the effectiveness
of any provision hereof. This Agreement may not be changed, amended or modified as to any particular provision, except by a written instrument
executed by all parties hereto, and cannot be terminated orally or by course of conduct. No provision hereof can be waived, except by
a writing signed by the party against whom such waiver is to be enforced, and any such waiver shall apply only in the particular instance
in which such waiver shall have been given.

 

11.
Further Assurances. Each party shall do and perform, or cause to be done and performed, all such further acts and things, and
shall execute and deliver all such other agreements, certificates, instruments and documents, as may reasonably be considered within
the scope of such party’s obligations hereunder, in order to carry out the intent and accomplish the purposes of this Agreement
and the consummation of the transactions contemplated hereby.

 

12.
No Strict Construction. The language used in this Agreement will be deemed to be the language chosen by the parties to express
their mutual intent, and no rules of strict construction will be applied against any party.

  

13.
Dispute Resolution. Section 11.15 and 11.16 of the Merger Agreement is incorporated by reference herein to apply with full force
to any disputes arising under this Agreement.

 

14.
Governing Law. Section 11.7 of the Merger Agreement is incorporated by reference herein to apply with full force to any disputes
arising under this Agreement.

 

 

[Signature
Page Follows]

 

    4

     

    

 

IN
WITNESS WHEREOF, the parties hereto have caused this Lock-up Agreement to be duly executed by their respective authorized signatories
as of the date first indicated above.

 

	 	Viveon
    Health Acquisition Corp.
	 	 	 
	 	By:	 
	 	Name: 	[●]
	 	Title:	[●]
	 	 	 
	 	HOLDER:
	 	 	 
	 	By:	 
	 	Name: 	 
	 	Title:	 

 

 

5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00338-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00338-of-00352.parquet"}]]